On this page · 5 sections→
Where the EU money came from
Funding by EU programme. Amounts are Externautics SpA's own share of each project, not the project's full budget.
- FP7 (2007 to 2013)€531k · 2 projects
Projects
2 EU-funded projects, newest first. Each links to the official record.
- OMVACPartner
Outer Membrane Vesicles (OMVs) from “Vaccinobacter”: A Synthetic Biology approach for effective vaccines against infectious diseases and cancer
FP7 (2007 to 2013) · 2014–2019 · Project on CORDIS ↗
€256ktheir share - IMPROVEPartner
Improving Prostate Cancer Outcome with Vectored Vaccines
FP7 (2007 to 2013) · 2014–2019 · Project on CORDIS ↗
€275ktheir share
Works most with
Organisations that shared the most EU projects with this one. A good starting list for consortium partners.
- The Chancellor, Masters and Scholars of the University of OxfordUnited Kingdom · 1 shared project
- Universita Degli Studi di TrentoItaly · 1 shared project
- Universite de LausanneSwitzerland · 1 shared project
- Fondazione Toscana Life SciencesItaly · 1 shared project
- Glaxosmithkline Vaccines SRLItaly · 1 shared project
- Astrazeneca Computational Pathology GmbHGermany · 1 shared project
- Oxford Biomedica (UK) LimitedUnited Kingdom · 1 shared project
- Vaccitech LtdUnited Kingdom · 1 shared project
Fields it works in
Research fields recorded on its Horizon projects.
- immunology
- infectious diseases
- oncology
- prostate cancer
- synthetic biology
- vaccines
Is this your organisation?
Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.
Claim this profile →Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships.